We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BioCircuit Technologies and Smithfield BioScience have teamed up to develop and commercialize a medical device that provides suture-less nerve repair after traumatic injuries. Read More
Salt Lake City, Utah-based ReddyPort has patented a novel device that allows patients undergoing noninvasive ventilation (NIV) to communicate. Read More
Cosmos Pharmaceuticals’ artificial intelligence (AI)-assisted GI Genius endoscopy module significantly reduced the miss rate of colorectal tumors by two times in a recent clinical trial when used in conjunction with colonoscopy. Read More
San Francisco, Calif-based prescription digital therapeutics company Blue Note Therapeutics has teamed up with clinical trial administrator Curebase for a “virtual” clinical trial to reach patients with cancer-related distress. Read More
Immunodiagnostics developer Oncimmune has inked a contract with Alphabet subsidiary Verily Life Sciences to conduct autoantibody profiling on patients who have developed long COVID-19, defined as a symptomatic case of COVID-19 that lasts for more than four weeks. Read More
A clinical trial of KidneyIntelX’s Renalytix chronic kidney disease diagnostic tool showed that it can accurately forecast the rate of patients’ decline in kidney function, the company said. Read More
Irvine, Calif.-based enVVeno Medical has released promising data from a first-in-human study of its VenoValve implant for the treatment of chronic venous insufficiency (CVI). Read More
An international trial evaluating Elixir Medical’s DynamX Bioadaptor drug-eluting coronary artery implant has completed enrollment of 444 patients across 35 centers in Japan, Europe and New Zealand, the company said. Read More
Clearwater, Fla.-based Apyx Medical’s Renuvion dermal handpiece with the company’s helium plasma technology for dermal resurfacing succeeded in treating wrinkles in a clinical trial, researchers reported in the journal Lasers in Surgery and Medicine. Read More
Patients with nonsurgical refractory back pain (NSRBP) treated with Nevro’s Senza high-frequency 10-kHz spinal cord stimulation (SCS) device saw a significant improvement in a clinical trial. Read More
Therma Bright said it is “the first company in the COVID-19 diagnostic testing space to successfully complete a 15-minute rapid antigen saliva-based U.S. study.” Read More